Antitumor effect of adriamycin-encapsulated nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran

Journal of Pharmaceutical Sciences

Volumn 98, Issue 6, 2009, Pages 2104-2112

  Choi, Ki Choon ^a   Bang, Je Yong ^b   Kim, Chan ^c   Kim, Pyoung Il ^d   Lee, Sang Rak ^e   Chung, Wan Tae ^f   Park, Woo Dae ^a   Park, Jung Sun ^g   Yeon, Soo Lee ^h   Song, Chae Eun ⁱ   Lee, Hye Young ^j  

^a Seojeong College University   (South Korea)

^b Seoul Women University   (South Korea)

^c AMOMEDI Co Ltd   (South Korea)

^d Seoul National University   (South Korea)

^e Konkuk University   (South Korea)

^f National Institute of Animal Science   (South Korea)

^g Chonnam National University Medical School   (South Korea)

^h Gwangju Institute of Science and Technology (GIST)   (South Korea)

ⁱ Korea Institute of Natural Science Inc   (South Korea)

^j Seokyeong University   (South Korea)

more..

Author keywords

Adriamycin; Core shell type nanoparticles; CT 26 colorectal tumor; Dextran; Poly(DL lactide co glycolide)

Indexed keywords

DEXLG 1; DEXLG 2; DEXLG 3; DEXTRAN; DOXORUBICIN; POLYGLACTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; FREEZE DRYING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 67049088511     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21588     Document Type: Article

References (20)

1. Allemann E, Gurny R, Doelker E. 1993. Drug-loaded nanoparticles - Preparation methods and drug targeting issues. Eur J Pharm Biopharm 39:173-191. (Pubitemid 23361352)
2. Kreuter J. 1988. Possibilities of using nanoparticles as carriers for drugs and vaccines. J Microencapsul 5:115-127. (Pubitemid 18154262)
3. Estey E, Thall PF, Mehta K, Rosenblum M, Brewer T, Jr., Simmons V, Cabanillas F, Kurzrock R, Lopez-Berestein G. 1996. Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid. Blood 87:3650-3654. (Pubitemid 26130612)
4. Kataoka K, Kwon GS, Yokohama M, Okano T, Sakurai Y. 1993. Block copolymer micelles as vehicles for drug delivery. J Control Release 24:119-132. (Pubitemid 23161325)
5. La SB Okano, T, Kataoka K. 1996. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles. J Pharm Sci 85:85-90. (Pubitemid 26029075)
6. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. 1994. Biodegradable long-circulating polymeric nanospheres. Science 263:1600-1603. (Pubitemid 24128361)
7. Jeong YI, Cheon JB, Kim SH, Nah JW, Lee YM, Sung YK, Akaike T, Cho CS. 1998. Clonazepam release from core-shell type nanoparticles in vitro. J Control Release 51:169-178. (Pubitemid 28252868)
8. Lehn JM. 1993. Supramolecular chemistry. Science 260:1762-1763. (Pubitemid 23958156)
9. Akiyoshi K, Kobayashi S, Shichibe S, Mix D, Baudys M, Kim SW, Sunamoto J. 1998. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin. J Control Release 54:313-320. (Pubitemid 28412662)
10. Jeong YI, Choi KC, Song CE. 2006. Doxorubicin release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran. Arch Pharm Res 29:712-719. (Pubitemid 44338471)
11. Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K. 1991. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res 51:3229-3236.
12. Ichinose K, Tomiyama N, Nakashima M, Ohya Y, Ichikawa M, Ouchi T, Kanematsu T. 2000. Antitumor activity of dextran derivatives immobilizing platinum complex (II). Anticancer Drugs 11:33-38. (Pubitemid 30166702)
13. Mehvar R. 2003. Recent trends in the use of polysaccharides for improved delivery of therapeutic agents: Pharmacokinetic and pharmacodynamic perspectives. Curr Pharm Biotech 4:283-302. (Pubitemid 37220861)
14. Molteni L. 1985. Dextran and inulin conjugates as drug carriers. Methods Enzymol 112:285-298. (Pubitemid 15036589)
15. Nishikawa T, Akiyoshi K, Sunamoto J. 1994. Supramolecular assembly between nanoparticles of hydrophobized polysaccharide and soluble protein complexation between the self-aggregate of cholesterol-bearing pullulan and α-chymotrypsin. Macromolecules 27:7654-7659.
16. Van Dijk-Wolthuis WNE, Franssen O, Talsma H, Van Steenbergen MJ, Kettenes-Van den Bosch JJ, Hennink WE. 1995. Synthesis, characterization, and polymerization of glycidyl methacrylate derivatized dextran. Macromolecules 28:6317-6322.
17. Jung SW, Jeong YI, Kim YH, Choi KC, Kim SH. 2005. Drug release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran. J Microencapsul 22:901-911. (Pubitemid 43158191)
18. Jeong YI, Shim YH, Kim C, Lim GT, Choi KC, Yoon C. 2005. Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(DL-lactide-co-glycolide). J Microencapsul 22:593-601. (Pubitemid 43102156)
19. Konan YN, Gurny R, Allemann E. 2002. Preparation and characterization of sterile and free-dried sub-200 nm nanoparticles. Int J Pharm 233:239-252. (Pubitemid 34230436)
20. Zimmermann E, Muller RH, Mader K. 2000. Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharm 196:211-213. (Pubitemid 30105745)